US Federal 2025-2026 Regular Session

US Federal Senate Bill SB744

Introduced
 
Introduced
2/26/25  

Caption

Maintaining American Superiority by Improving Export Control Transparency Act

Summary

SB 744, the Maintaining American Superiority by Improving Export Control Transparency Act, would amend the Export Control Reform Act of 2018 to require the Secretary responsible for export controls to submit annual reports to Congress on certain export license applications, enforcement actions, and other authorization requests involving controlled items sent to covered entities. The reports would have to include detailed information for each application or request, such as the submitting entity, a description of the item, the ECCN and level of control if applicable, the end-user and its location, the estimated value, the decision on the request, and the submission date. They would also need to include information on related enforcement activities, such as end-use checks, plus aggregate statistics on all such requests. The bill is designed to increase congressional visibility into exports, reexports, releases, and in-country transfers of controlled items to entities located or operating in countries in Country Group D:5 and listed on specified restricted-entity lists under the Export Administration Regulations. While the bill requires detailed reporting to Congress, it also protects most of the information from public disclosure, allowing only aggregate statistics to be released publicly. The measure would therefore change federal export-control reporting requirements without altering the underlying licensing standards themselves. The available context shows the bill was introduced by Senators Banks and Warner and referred to the Senate Committee on Banking, Housing, and Urban Affairs, but there are no recorded committee transcripts or votes in the provided material. As a result, there is no direct evidence of debate, amendments, or formal opposition in the record supplied here. The absence of voting history suggests the bill was still in an early stage of consideration at the time of the provided information. Overall, the bill appears to be framed as a transparency and oversight measure rather than a substantive loosening or tightening of export controls. Its main practical effect would be to give Congress more detailed, recurring information about sensitive export-control decisions and enforcement activity involving high-risk destinations and entities, while keeping most transaction-level information confidential.

Impact

SB 744 would amend section 1756 of the Export Control Reform Act of 2018 to add a new annual reporting requirement for export-control licensing and enforcement activity involving covered entities. It would require the executive branch to provide Congress with detailed, transaction-level information on license applications and other authorization requests, plus enforcement actions, while exempting most of that information from public disclosure. The bill would not directly change export licensing criteria, but it would increase oversight obligations and reporting burdens for the administering agency and create a new statutory transparency framework for Congress.

Sentiment

Based on the limited available record, the bill appears to have a generally favorable and bipartisan tone, as it was introduced by Senators Banks and Warner together. The title and structure suggest a shared interest in strengthening congressional oversight of sensitive exports. However, because there are no committee transcripts or votes provided, there is no documented floor or committee sentiment to indicate broader support or opposition beyond the sponsors' introduction of the measure.

Contention

The main potential point of contention is the balance between transparency and confidentiality. Supporters are likely to favor more detailed congressional reporting on export licenses, end-users, and enforcement actions, especially for sensitive destinations and restricted entities. Critics could be concerned about administrative burden, the sensitivity of the information being collected, and whether the reporting requirements could expose proprietary or national-security-related details, even though the bill exempts most of the information from public release. Another possible issue is whether the bill meaningfully improves oversight without affecting the speed or flexibility of export-control administration.

Companion Bills

US HB1316

Same As Maintaining American Superiority by Improving Export Control Transparency Act

Previously Filed As

US HB1316

Maintaining American Superiority by Improving Export Control Transparency Act

US HB8288

Strengthening Export Controls Compliance Act

US HB8959

Semiconductor Superiority Act

US HB8036

Interagency Coordination in Export Controls Act of 2026

US HB8169

Export Control Enforcement and Enhancement Act

US HB8285

Protecting American Competition Act of 2026

US HB8283

Deterring American AI Model Theft Act of 2026

US S0117

Sets controls on Medicaid prescription drug costs by imposing transparency and accountability requirements on managed care organizations (MCOs) and their pharmacy benefit managers (PBMs).

US H5463

Sets controls on Medicaid prescription drug costs by imposing transparency and accountability requirements on managed care organizations (MCOs) and their pharmacy benefit managers (PBMs).

US H7692

Sets controls on Medicaid prescription drug costs by imposing transparency and accountability requirements on managed care organizations (MCOs) and their pharmacy benefit managers (PBMs).

Similar Bills

No similar bills found.